Systematic Financial Management LP Increases Stake in Healthpeak Properties, Inc. $DOC

Systematic Financial Management LP increased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 10.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,839,564 shares of the real estate investment trust’s stock after buying an additional 172,425 shares during the period. Systematic Financial Management LP’s holdings in Healthpeak Properties were worth $30,224,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Fiduciary Trust Co grew its stake in shares of Healthpeak Properties by 4.9% in the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after acquiring an additional 644 shares in the last quarter. Patton Fund Management Inc. increased its position in shares of Healthpeak Properties by 5.2% during the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after acquiring an additional 648 shares during the period. Quadrant Capital Group LLC raised its stake in shares of Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after acquiring an additional 718 shares in the last quarter. Quantum Portfolio Management LLC raised its stake in shares of Healthpeak Properties by 2.5% in the first quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust’s stock valued at $483,000 after acquiring an additional 728 shares in the last quarter. Finally, Intrua Financial LLC raised its stake in shares of Healthpeak Properties by 1.1% in the first quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust’s stock valued at $1,096,000 after acquiring an additional 744 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Mizuho boosted their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Citigroup upped their price target on Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research report on Thursday, June 11th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, UBS Group boosted their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.62.

Insider Transactions at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Price Performance

Shares of DOC opened at $22.08 on Friday. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.77. The firm’s fifty day simple moving average is $20.68 and its 200-day simple moving average is $18.43. The firm has a market capitalization of $15.22 billion, a price-to-earnings ratio of 68.99, a PEG ratio of 3.45 and a beta of 1.02. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 5.5%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.